TickerFactsScreenerDevelopers

ImmunityBio, Inc. (IBRX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2015: $10.85M2016: $24.08M2017: $31.60M2018: $35.94M2019: $22.44M2020: $339.87M2021: $712.82M2022: $812.18M2023: $1.09B2024: $871.06M2025: $1.00B$1.00B
2015Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$1.00B+15.0%
2024$871.06M-20.1%
2023$1.09B+34.3%
2022$812.18M+13.9%
2021$712.82M+109.7%
2020$339.87M+1414.3%
2019$22.44M-37.6%
2018$35.94M+13.8%
2017$31.60M+31.2%
2016$24.08M+121.8%
2015$10.85M—